975 related articles for article (PubMed ID: 15713540)
1. In vitro models for the blood-brain barrier.
Garberg P; Ball M; Borg N; Cecchelli R; Fenart L; Hurst RD; Lindmark T; Mabondzo A; Nilsson JE; Raub TJ; Stanimirovic D; Terasaki T; Oberg JO; Osterberg T
Toxicol In Vitro; 2005 Apr; 19(3):299-334. PubMed ID: 15713540
[TBL] [Abstract][Full Text] [Related]
2. Porcine brain microvessel endothelial cells as an in vitro model to predict in vivo blood-brain barrier permeability.
Zhang Y; Li CS; Ye Y; Johnson K; Poe J; Johnson S; Bobrowski W; Garrido R; Madhu C
Drug Metab Dispos; 2006 Nov; 34(11):1935-43. PubMed ID: 16896068
[TBL] [Abstract][Full Text] [Related]
3. How well can in vitro brain microcapillary endothelial cell models predict rodent in vivo blood-brain barrier permeability?
Avdeef A
Eur J Pharm Sci; 2011 Jun; 43(3):109-24. PubMed ID: 21514381
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the MDR-MDCK cell line as a permeability screen for the blood-brain barrier.
Wang Q; Rager JD; Weinstein K; Kardos PS; Dobson GL; Li J; Hidalgo IJ
Int J Pharm; 2005 Jan; 288(2):349-59. PubMed ID: 15620875
[TBL] [Abstract][Full Text] [Related]
5. Relationship between in vitro transendothelial permeability and in vivo single-pass brain extraction.
Pirro JP; Di Rocco RJ; Narra RK; Nunn AD
J Nucl Med; 1994 Sep; 35(9):1514-9. PubMed ID: 8071703
[TBL] [Abstract][Full Text] [Related]
6. Development of an in vitro blood-brain barrier model-cytotoxicity of mercury and aluminum.
Toimela T; Mäenpää H; Mannerström M; Tähti H
Toxicol Appl Pharmacol; 2004 Feb; 195(1):73-82. PubMed ID: 14962507
[TBL] [Abstract][Full Text] [Related]
7. A new blood-brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes.
Nakagawa S; Deli MA; Kawaguchi H; Shimizudani T; Shimono T; Kittel A; Tanaka K; Niwa M
Neurochem Int; 2009; 54(3-4):253-63. PubMed ID: 19111869
[TBL] [Abstract][Full Text] [Related]
8. Induction of blood-brain barrier properties in cultured brain capillary endothelial cells: comparison between primary glial cells and C6 cell line.
Boveri M; Berezowski V; Price A; Slupek S; Lenfant AM; Benaud C; Hartung T; Cecchelli R; Prieto P; Dehouck MP
Glia; 2005 Aug; 51(3):187-98. PubMed ID: 15800928
[TBL] [Abstract][Full Text] [Related]
9. Characterization of an "in vitro" blood-brain barrier: effects of molecular size and lipophilicity on cerebrovascular endothelial transport rates of drugs.
van Bree JB; de Boer AG; Danhof M; Ginsel LA; Breimer DD
J Pharmacol Exp Ther; 1988 Dec; 247(3):1233-9. PubMed ID: 3204515
[TBL] [Abstract][Full Text] [Related]
10. Comparison of in vitro and in vivo models of drug transcytosis through the blood-brain barrier.
Pardridge WM; Triguero D; Yang J; Cancilla PA
J Pharmacol Exp Ther; 1990 May; 253(2):884-91. PubMed ID: 2338660
[TBL] [Abstract][Full Text] [Related]
11. Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier.
Steuer H; Jaworski A; Elger B; Kaussmann M; Keldenich J; Schneider H; Stoll D; Schlosshauer B
Invest Ophthalmol Vis Sci; 2005 Mar; 46(3):1047-53. PubMed ID: 15728564
[TBL] [Abstract][Full Text] [Related]
12. Comparison of brain capillary endothelial cell-based and epithelial (MDCK-MDR1, Caco-2, and VB-Caco-2) cell-based surrogate blood-brain barrier penetration models.
Hellinger E; Veszelka S; Tóth AE; Walter F; Kittel A; Bakk ML; Tihanyi K; Háda V; Nakagawa S; Duy TD; Niwa M; Deli MA; Vastag M
Eur J Pharm Biopharm; 2012 Oct; 82(2):340-51. PubMed ID: 22906709
[TBL] [Abstract][Full Text] [Related]
13. Functional expression and localization of P-glycoprotein at the blood brain barrier.
Bendayan R; Lee G; Bendayan M
Microsc Res Tech; 2002 Jun; 57(5):365-80. PubMed ID: 12112443
[TBL] [Abstract][Full Text] [Related]
14. Puromycin-based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood-brain barrier-specific properties.
Perrière N; Demeuse P; Garcia E; Regina A; Debray M; Andreux JP; Couvreur P; Scherrmann JM; Temsamani J; Couraud PO; Deli MA; Roux F
J Neurochem; 2005 Apr; 93(2):279-89. PubMed ID: 15816851
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of various PAMPA models to identify the most discriminating method for the prediction of BBB permeability.
Mensch J; Melis A; Mackie C; Verreck G; Brewster ME; Augustijns P
Eur J Pharm Biopharm; 2010 Mar; 74(3):495-502. PubMed ID: 20067834
[TBL] [Abstract][Full Text] [Related]
16. A dynamic model of the blood-brain barrier "in vitro".
Stanness KA; Guatteo E; Janigro D
Neurotoxicology; 1996; 17(2):481-96. PubMed ID: 8856743
[TBL] [Abstract][Full Text] [Related]
17. Comparison of in vitro cell models in predicting in vivo brain entry of drugs.
Hakkarainen JJ; Jalkanen AJ; Kääriäinen TM; Keski-Rahkonen P; Venäläinen T; Hokkanen J; Mönkkönen J; Suhonen M; Forsberg MM
Int J Pharm; 2010 Dec; 402(1-2):27-36. PubMed ID: 20920560
[TBL] [Abstract][Full Text] [Related]
18. Polarized P-glycoprotein expression by the immortalised human brain endothelial cell line, hCMEC/D3, restricts apical-to-basolateral permeability to rhodamine 123.
Tai LM; Reddy PS; Lopez-Ramirez MA; Davies HA; Male DK; Loughlin AJ; Romero IA
Brain Res; 2009 Oct; 1292():14-24. PubMed ID: 19631619
[TBL] [Abstract][Full Text] [Related]
19. Transport of cationized anti-tetanus Fab'2 fragments across an in vitro blood-brain barrier model: involvement of the transcytosis pathway.
Girod J; Fenart L; Régina A; Dehouck MP; Hong G; Scherrmann JM; Cecchelli R; Roux F
J Neurochem; 1999 Nov; 73(5):2002-8. PubMed ID: 10537059
[TBL] [Abstract][Full Text] [Related]
20. Murine in vitro model of the blood-brain barrier for evaluating drug transport.
Shayan G; Choi YS; Shusta EV; Shuler ML; Lee KH
Eur J Pharm Sci; 2011 Jan; 42(1-2):148-55. PubMed ID: 21078386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
